Stem cell patch for treating macular degeneration to enter phase 2b clinical trial

A stem cell patch developed by USC researchers for patients with macular degeneration will soon be tested in a phase 2b clinical trial.

Related Keywords

California ,United States ,Americans ,David Hinton ,Santa Barbara ,Mark Humayun ,Lily Ramsey ,Rodrigo Antonio Brant Fernandes ,Sun Young Lee ,Dennis Clegg ,Mariat Millan ,Caroll Folt ,Roski Eye Institute ,Marcus Foundation In Atlanta ,University Of California ,Edward Roski Eye Institute ,Centers For Disease ,Stevens Center ,California Institute For Regenerative Medicine ,Marcus Foundation ,Ginsburg Institute For Biomedical Therapeutics ,Alfrede Mann Institute ,California Institute ,Regenerative Medicine ,Regenerative Patch Technologies ,Biomedical Therapeutics ,Edward Roski Eye ,Disease Control ,Cure Blindness Retinal Pigment Epithelium ,Regenerative Patch ,Clinical Trial ,Eye ,Age Related Macular Degeneration ,Blindness ,Fell ,Efficacy ,Macular Degeneration ,Medicine ,Research ,Technology ,